CD276 and neoplasm: Recent studies have shown that CD276 and B7-H4 have a co-inhibitory role on T-cells, participating in tumor cell immune evasion, whose overexpression has a significant relationship with poor prognosis in tumor patients (Altan et al., 2017), which was consistent with the prognostic value of COL1A1.